Figure 1From: Immunomodulation therapy with lenalidomide in follicular, transformed and diffuse large B cell lymphoma: current data on safety and efficacyLenalidomide possesses a diverse set of mechanism of action in the tumor microenvironment. These actions include direct growth inhibition, apoptosis induction, anti-tumor immune response, and anti-angiogenesis.Back to article page